" The 350-mg dose of leronlimab significantly lowered cT1 from baseline to week 14 even in participants with moderate or severe cT1 values at baseline."

Even with severe.

I know 350/700 is talked on, but what about the past inbetween of 525 mg ? Possible?

I don't have a medical clue on that.

Anywho, we have an outstanding "problem" on our hands, aka: determining the dosing for each criteria.

: )